CRM Trial Connect Conference 2024
The CRM Trial Connect 2024 is on its third consecutive year and was held in collaboration with the European Organization for Research & Treatment of Cancer (EORTC) and the National Cancer Center Japan. The conference was aimed to showcase Malaysia’s accomplishments in sponsored clinical research and promote collaborations between local and international clinical research stakeholders.
CRM and AstraZeneca Won the Prestigious Business Excellence Award 2024 for UK-Malaysia Partnership of the Year!
We are thrilled about this remarkable achievement at the fifth Business Excellence Award (BEA) 2024, hosted by the British Malaysian Chamber of Commerce (BMCC). AstraZeneca and Clinical Research Malaysia have won the prestigious UK-Malaysia Partnership of the Year Award, encompassing clinical trials, governance meetings, and site visits.
Malaysia’s Record-Breaking Success in Sponsored Clinical Research
Malaysia reaches new peaks in clinical research! In 2023, Malaysia has achieved 276 studies, securing our spot as Southeast Asia’s #2 for global industry-sponsored research.
Announcement: Increase of Sales & Service Tax
Commencing from 1 March 2024, the rate of Service Tax under the Service Tax 2018 is increased from 6% to 8%.
Kickstart Your Career in Clinical Trials!
Embark on your journey with our comprehensive 12-week Study Coordinator training program!
Roche Pharmaceuticals Selects Sarawak General Hospital as a Site for Its Global First-in-Human Clinical Trial
Roche Pharmaceuticals, one of the world’s largest pharmaceutical companies has confirmed Sarawak General Hospital as Site for a First-in-Human (FIH) clinical trial in Malaysia.
Partnership to Advance Nation’s Clinical Research Capabilities
Clinical Research Malaysia (CRM) and the Pharmaceutical Association of Malaysia (PhAMA) have entered a strategic partnership to propel the development of clinical research talents and skills in Malaysia
Malaysia Scores Big in International Oncology Conference
Malaysian oncologists garnered attention for their active involvement and co-authorship in studies, with a particular focus on two studies showcasing promising outcomes for new lung cancer treatments. This underscores Malaysia’s increasing influence in global oncology research.
Malaysia On Par with Global Top-Ranking Cancer Institutes
Malaysia made history this month when one of its Medical Oncologist, Dr Voon Pei Jye from Sarawak General Hospital (SGH) became the first Malaysian to be invited to co-author a First-in-Human trial publication.
